AMPK对于生理性细胞和球功能是不可或缺的,但在实验性糖尿病中可以预防球纤维化
bioRxiv : the preprint server for biology
|April 28, 2025
概括
AMP激活蛋白激酶 (AMPK) 对于健康的细胞功能并不重要,但通过减少纤维化,脂毒性和炎症,对于预防糖尿病损伤至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 代谢疾病 代谢疾病
背景情况:
- AMP激活蛋白激酶 (AMPK) 在脏生理学和病理生理学中发挥作用.
- 它在细胞中的特定功能对于球膜过至关重要,仍未得到充分研究.
- 需要基因模型来研究小细胞AMPK的作用.
研究的目的:
- 通过基因淘汰赛小鼠模型,研究AMPK在质细胞中的作用.
- 为了确定 podocyte 特定的 AMPK 是否对正常功能至关重要.
- 为了评估 podocyte AMPK 缺乏对糖尿病病的影响.
主要方法:
- 生成的 podocyte 特定的 AMPK 淘汰小鼠 (pmut) 缺乏 α1 和 α2 催化子单元.
- 在正常和1型糖尿病条件下,评估了年轻和老年淘汰赛小鼠的球和功能.
- 在高葡萄糖条件下对基因表达和线粒体完整性进行分析.
主要成果:
- 细胞特异性AMPK淘汰小鼠在健康的脏中没有异常,寿命与野生类型的 littermates一样长.
- 患有糖尿病的pmut小鼠表现出增加的白蛋白尿,质脂和原积累,以及介酶蛋白表达.
- 在高葡萄糖下,从pmut小鼠中分离出来的质体显示出线粒体基因表达的减少,线粒体泄漏,以及增强的促炎途径.
结论:
- 在健康脏中,AMPK对于正常的 podocyte 功能是不可或缺的.
- 细胞AMPK对于减轻球纤维化,脂毒性和1型糖尿病病症的炎症至关重要.
- 准 podocyte AMPK 可能为糖尿病病提供治疗策略.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Dipeptidyl Peptidase 4 Inhibitors
117
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
117


